Mouhammad ZA, Vohra R, Horwitz A, Thein AS, Rovelt J, Cvenkel B, Williams PA, Azuara-Blanco A, Kolko M (2022) Glucagon-Like Peptide 1 Receptor Agonists -Potential Game Changers in the Treatment of Glaucoma
Bigini P, Larini S, et al
reimbursement eligibility depends on individual plan rules States served: 49, per VivioMD
These effects could potentially reduce recovery time and improve functional outcomes in patients with muscle injuries
Potential mechanisms include rapid blood glucose fluctuations, dehydration from reduced appetite, changes in vascular tone, and dose escalation speed